Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents

Several synthetic curcumin analogues, especially 32 and 34, exhibited highly selective cytotoxicity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, suggesting their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. A seri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2011-02, Vol.21 (3), p.1010-1014
Hauptverfasser: Zhang, Qin, Zhong, Ying, Yan, Lin-Na, Sun, Xun, Gong, Tao, Zhang, Zhi-Rong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1014
container_issue 3
container_start_page 1010
container_title Bioorganic & medicinal chemistry letters
container_volume 21
creator Zhang, Qin
Zhong, Ying
Yan, Lin-Na
Sun, Xun
Gong, Tao
Zhang, Zhi-Rong
description Several synthetic curcumin analogues, especially 32 and 34, exhibited highly selective cytotoxicity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, suggesting their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. A series of curcumin analogues with different substituents at the 4-position of the phenyl group were synthesized and screened for in vitro cytotoxicity against a panel of human cancer cell lines. Several novel curcumin analogues, especially 32 and 34, exhibited selective and potent cytotoxic activity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, implying their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. The preliminary SAR information extracted from the results suggested that introduction of appropriate substituents to the 4′-positions could be a promising approach for the development of new cytotoxic curcumin analogues with special selectivity for A-431 and U-251 cell lines.
doi_str_mv 10.1016/j.bmcl.2010.12.020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_883016018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X10017749</els_id><sourcerecordid>847283892</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-f3aa966e152094e27f1ebf3615851a44463dbb929aa16979734eba075466ddb83</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EokvhD3CAXBCnLP6YOLHEpar4kqr2UCpxsybOZPEqiRc7qdh_j1e7wK3qydL4eWdGzzD2WvC14EJ_2K7b0Q1ryQ8FueaSP2ErARpKBbx6ylbcaF42Bn6csRcpbTkXwAGeszMppKi0NCt2fbuf5p-UfCpw6opdpMGPfsK4L-gehwVnH6Yi9IVbolvyT8ZwCJuFciAVbj-HOfz2rsANTXN6yZ71OCR6dXrP2d3nT98vv5ZXN1--XV5clQ5AzGWvEI3WJCrJDZCse0Ftr7SomkogAGjVta2RBlFoU5taAbXI6wq07rq2Uefs_bHvLoZfeZfZjj45GgacKCzJNo3Khrh4BAm1bFRjZCblkXQxpBSpt7vox2zCCm4Pwu3WHoTbg3ArpM3Cc-jNqf3SjtT9i_w1nIF3JwCTw6GPODmf_nOqkaZSdebeHrkeg8VNzMzdbZ5U5aspULXOxMcjQVnsvadok_M0Oep8JDfbLviHNv0DpIynUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>847283892</pqid></control><display><type>article</type><title>Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zhang, Qin ; Zhong, Ying ; Yan, Lin-Na ; Sun, Xun ; Gong, Tao ; Zhang, Zhi-Rong</creator><creatorcontrib>Zhang, Qin ; Zhong, Ying ; Yan, Lin-Na ; Sun, Xun ; Gong, Tao ; Zhang, Zhi-Rong</creatorcontrib><description>Several synthetic curcumin analogues, especially 32 and 34, exhibited highly selective cytotoxicity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, suggesting their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. A series of curcumin analogues with different substituents at the 4-position of the phenyl group were synthesized and screened for in vitro cytotoxicity against a panel of human cancer cell lines. Several novel curcumin analogues, especially 32 and 34, exhibited selective and potent cytotoxic activity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, implying their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. The preliminary SAR information extracted from the results suggested that introduction of appropriate substituents to the 4′-positions could be a promising approach for the development of new cytotoxic curcumin analogues with special selectivity for A-431 and U-251 cell lines.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.12.020</identifier><identifier>PMID: 21215629</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - toxicity ; Biological and medical sciences ; carcinoma ; Cell Line, Tumor ; chemoprevention ; chemotherapy ; curcumin ; Curcumin - analogs &amp; derivatives ; Curcumin - chemical synthesis ; Curcumin - chemistry ; Curcumin - toxicity ; Curcumin analogues ; Cytotoxicity ; Drug Screening Assays, Antitumor ; General aspects ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; skin neoplasms ; Structure-Activity Relationship ; Synthesis</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2011-02, Vol.21 (3), p.1010-1014</ispartof><rights>2011</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-f3aa966e152094e27f1ebf3615851a44463dbb929aa16979734eba075466ddb83</citedby><cites>FETCH-LOGICAL-c441t-f3aa966e152094e27f1ebf3615851a44463dbb929aa16979734eba075466ddb83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X10017749$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23829537$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21215629$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Qin</creatorcontrib><creatorcontrib>Zhong, Ying</creatorcontrib><creatorcontrib>Yan, Lin-Na</creatorcontrib><creatorcontrib>Sun, Xun</creatorcontrib><creatorcontrib>Gong, Tao</creatorcontrib><creatorcontrib>Zhang, Zhi-Rong</creatorcontrib><title>Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Several synthetic curcumin analogues, especially 32 and 34, exhibited highly selective cytotoxicity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, suggesting their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. A series of curcumin analogues with different substituents at the 4-position of the phenyl group were synthesized and screened for in vitro cytotoxicity against a panel of human cancer cell lines. Several novel curcumin analogues, especially 32 and 34, exhibited selective and potent cytotoxic activity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, implying their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. The preliminary SAR information extracted from the results suggested that introduction of appropriate substituents to the 4′-positions could be a promising approach for the development of new cytotoxic curcumin analogues with special selectivity for A-431 and U-251 cell lines.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Biological and medical sciences</subject><subject>carcinoma</subject><subject>Cell Line, Tumor</subject><subject>chemoprevention</subject><subject>chemotherapy</subject><subject>curcumin</subject><subject>Curcumin - analogs &amp; derivatives</subject><subject>Curcumin - chemical synthesis</subject><subject>Curcumin - chemistry</subject><subject>Curcumin - toxicity</subject><subject>Curcumin analogues</subject><subject>Cytotoxicity</subject><subject>Drug Screening Assays, Antitumor</subject><subject>General aspects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>skin neoplasms</subject><subject>Structure-Activity Relationship</subject><subject>Synthesis</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhi0EokvhD3CAXBCnLP6YOLHEpar4kqr2UCpxsybOZPEqiRc7qdh_j1e7wK3qydL4eWdGzzD2WvC14EJ_2K7b0Q1ryQ8FueaSP2ErARpKBbx6ylbcaF42Bn6csRcpbTkXwAGeszMppKi0NCt2fbuf5p-UfCpw6opdpMGPfsK4L-gehwVnH6Yi9IVbolvyT8ZwCJuFciAVbj-HOfz2rsANTXN6yZ71OCR6dXrP2d3nT98vv5ZXN1--XV5clQ5AzGWvEI3WJCrJDZCse0Ftr7SomkogAGjVta2RBlFoU5taAbXI6wq07rq2Uefs_bHvLoZfeZfZjj45GgacKCzJNo3Khrh4BAm1bFRjZCblkXQxpBSpt7vox2zCCm4Pwu3WHoTbg3ArpM3Cc-jNqf3SjtT9i_w1nIF3JwCTw6GPODmf_nOqkaZSdebeHrkeg8VNzMzdbZ5U5aspULXOxMcjQVnsvadok_M0Oep8JDfbLviHNv0DpIynUA</recordid><startdate>20110201</startdate><enddate>20110201</enddate><creator>Zhang, Qin</creator><creator>Zhong, Ying</creator><creator>Yan, Lin-Na</creator><creator>Sun, Xun</creator><creator>Gong, Tao</creator><creator>Zhang, Zhi-Rong</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20110201</creationdate><title>Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents</title><author>Zhang, Qin ; Zhong, Ying ; Yan, Lin-Na ; Sun, Xun ; Gong, Tao ; Zhang, Zhi-Rong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-f3aa966e152094e27f1ebf3615851a44463dbb929aa16979734eba075466ddb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Biological and medical sciences</topic><topic>carcinoma</topic><topic>Cell Line, Tumor</topic><topic>chemoprevention</topic><topic>chemotherapy</topic><topic>curcumin</topic><topic>Curcumin - analogs &amp; derivatives</topic><topic>Curcumin - chemical synthesis</topic><topic>Curcumin - chemistry</topic><topic>Curcumin - toxicity</topic><topic>Curcumin analogues</topic><topic>Cytotoxicity</topic><topic>Drug Screening Assays, Antitumor</topic><topic>General aspects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>skin neoplasms</topic><topic>Structure-Activity Relationship</topic><topic>Synthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Qin</creatorcontrib><creatorcontrib>Zhong, Ying</creatorcontrib><creatorcontrib>Yan, Lin-Na</creatorcontrib><creatorcontrib>Sun, Xun</creatorcontrib><creatorcontrib>Gong, Tao</creatorcontrib><creatorcontrib>Zhang, Zhi-Rong</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Qin</au><au>Zhong, Ying</au><au>Yan, Lin-Na</au><au>Sun, Xun</au><au>Gong, Tao</au><au>Zhang, Zhi-Rong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2011-02-01</date><risdate>2011</risdate><volume>21</volume><issue>3</issue><spage>1010</spage><epage>1014</epage><pages>1010-1014</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Several synthetic curcumin analogues, especially 32 and 34, exhibited highly selective cytotoxicity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, suggesting their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. A series of curcumin analogues with different substituents at the 4-position of the phenyl group were synthesized and screened for in vitro cytotoxicity against a panel of human cancer cell lines. Several novel curcumin analogues, especially 32 and 34, exhibited selective and potent cytotoxic activity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, implying their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. The preliminary SAR information extracted from the results suggested that introduction of appropriate substituents to the 4′-positions could be a promising approach for the development of new cytotoxic curcumin analogues with special selectivity for A-431 and U-251 cell lines.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>21215629</pmid><doi>10.1016/j.bmcl.2010.12.020</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2011-02, Vol.21 (3), p.1010-1014
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_883016018
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antineoplastic agents
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - toxicity
Biological and medical sciences
carcinoma
Cell Line, Tumor
chemoprevention
chemotherapy
curcumin
Curcumin - analogs & derivatives
Curcumin - chemical synthesis
Curcumin - chemistry
Curcumin - toxicity
Curcumin analogues
Cytotoxicity
Drug Screening Assays, Antitumor
General aspects
Humans
Medical sciences
Pharmacology. Drug treatments
skin neoplasms
Structure-Activity Relationship
Synthesis
title Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A00%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20preliminary%20evaluation%20of%20curcumin%20analogues%20as%20cytotoxic%20agents&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Zhang,%20Qin&rft.date=2011-02-01&rft.volume=21&rft.issue=3&rft.spage=1010&rft.epage=1014&rft.pages=1010-1014&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.12.020&rft_dat=%3Cproquest_cross%3E847283892%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=847283892&rft_id=info:pmid/21215629&rft_els_id=S0960894X10017749&rfr_iscdi=true